Baxter International Inc. products

The PrisMax System is designed to give healthcare professionals more confidence in the delivery of continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE) therapies.

The innovative Prismaflex System is designed to support the recovery of critically ill patients with acute kidney injury (AKI). The flexible system meets the demands of multiple therapies with a versatile platform that can be customized to specific patient needs.

The Oxiris set is available in select countries around the world. Oxiris is the only blood purification filter set to effectively remove inflammatory mediators, endotoxin, fluid, and uremic toxins simultaneously.

The Spectrum IQ Infusion System strives to set a new standard of care in the medication administration process, while also offering a simple, standardized user experience to help reduce human programming errors.

Myxredlin (Insulin Human) in 0.9% Sodium Chloride Injection is the first and only ready-to-use insulin for hospital care settings.

Designed for the future – the Evo IQ Infusion System. From market-leading experience comes the Evo IQ infusion system, with an array of features to help elevate the standard of patient safety, enhance clinician efficiency, and empower the adoption of new technologies, now and in the future

NUMETA G13E 300 mL is the only triple-chamber, ready-to-use parenteral (intravenous) nutrition (PN) product available to treat preterm infants (less than 37 weeks gestation age) who are at high risk for infection and malnutrition⁵ in the early hours and days of their lives.

Amia automated peritoneal dialysis (APD) with the Sharesource remote patient management platform is the first and only APD system to include user-friendly features that help guide end-stage renal disease patients through home peritoneal dialysis (PD) therapy, while keeping them remotely connected with their healthcare providers.

HDx enabled by THERANOVA is a new dialysis therapy we are pioneering for patients with end-stage renal disease. The THERANOVA dialyzer features an innovative membrane, which provides an expanded hemodialysis therapy (HDx).

Floseal is an effective adjunct hemostatic agent proven in a wide-range of bleeding scenarios¹ with a proprietary combination of two independent hemostatic agents.